tradingkey.logo
tradingkey.logo
Search

Crinetics Pharmaceuticals Announces FDA Approval Of Palsonifytm (Paltusotine) For Treatment Of Adults With Acromegaly

ReutersSep 25, 2025 9:51 PM
facebooktwitterlinkedin
View all comments0

- Crinetics Pharmaceuticals Inc CRNX.O:

  • CRINETICS PHARMACEUTICALS: ANNOUNCES FDA APPROVAL OF PALSONIFYTM (PALTUSOTINE) FOR TREATMENT OF ADULTS WITH ACROMEGALY

  • CRINETICS PHARMACEUTICALS: PALSONIFY IS EXPECTED TO BE AVAILABLE IN THE U.S. IN EARLY OCTOBER

Source text: [ID:]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI